Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression.
Interstitial lung disease
Magnetic resonance imaging
Systemic sclerosis
Journal
Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
20
08
2020
accepted:
29
10
2020
revised:
24
10
2020
pubmed:
9
11
2020
medline:
20
5
2021
entrez:
8
11
2020
Statut:
ppublish
Résumé
Interstitial lung disease (ILD) is frequent and highly disabling in systemic sclerosis (SSc). Magnetic resonance imaging (MRI) is not routinely used to evaluate the lung, due to poorer spatial resolution compared to high-resolution computed tomography (HRCT). We aimed to compare lung MRI signal with HRCT and evaluate the role of MRI in predicting ILD progression. Thirty SSc patients underwent lung MRI and HRCT. STIR and T1 mapping sequences were acquired before and after gadolinium injection. Patients were classified as normal (group 1 with normal HRCT and MRI), discordant (group 2 without ILD signs on HRCT but areas of hyperintensity on MRI), and abnormal (group 3 with ILD signs on HRCT and areas of hyperintensity on MRI). Patients were followed up for ILD progression. Mean STIR and T1 values were different between the three groups (p < 0.0001). STIR values correlated with HRCT score (R = 0.79, p < 0.0001), lung ultrasound B-lines (R = 0.73, p < 0.0001), and %DLco (R = - 0.63, p = 0.0001). Nine events were recorded during a follow-up of 25 ± 20 months. Continuous STIR values were independently associated with events (HR 1.018; CI 1.005-1.031, p = 0.005). A STIR value >90 ms discriminated patients at a higher risk of worsening pulmonary involvement (HR 8.80; CI 1.81-42.74; p < 0.007). Lung MRI can detect SSc-related ILD, with good correlations with other ILD markers. STIR values, independently of HRCT appearance, may predict worsening lung involvement. Lung MRI, although very preliminary, is a promising tool that in a near future could help selecting patients for an early treatment of SSc-related ILD and a more appropriate use of HRCT. Key points • Lung MRI has the potential to differentiate inflammation-predominant versus fibrosis-predominant lesions, but it is not currently used in routine clinical practice to assess SSc-related ILD. • Lung MRI STIR and T1 values are significantly different between patients with and without SSc-related ILD. STIR values, independently of HRCT appearance, are also able to predict worsening lung involvement over time. • These preliminary data suggest that, in a near future, MRI could support the choice for an early treatment of SSc-related ILD, as well as a more appropriate use of HRCT.
Identifiants
pubmed: 33161470
doi: 10.1007/s10067-020-05491-9
pii: 10.1007/s10067-020-05491-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1903-1912Références
Nihtyanova SI, Denton CP (2020) Pathogenesis of systemic sclerosis associated interstitial lung disease. Journal of Scleroderma and Related Disorders 5(2_suppl):6–16. https://doi.org/10.1177/2397198320903867
doi: 10.1177/2397198320903867
Varga J, Trojanowska M, Kuwana M (2017) Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities. Journal of Scleroderma and Related Disorders 2(3):137–152. https://doi.org/10.5301/jsrd.5000249
doi: 10.5301/jsrd.5000249
Volkmann ER, Fischer A Update on morbidity and mortality in systemic sclerosis–related interstitial lung disease. Journal of Scleroderma and Related Disorders 0 (0):2397198320915042. doi: https://doi.org/10.1177/2397198320915042
Barsotti S, Bruni C, Orlandi M, Della Rossa A, Marasco E, Codullo V, Guiducci S (2017) One year in review 2017: systemic sclerosis. Clin Exp Rheumatol 35 Suppl 106(4):3–20
Hoffmann-Vold A-M, Maher TM, Philpot EE, Ashrafzadeh A, Barake R, Barsotti S, Bruni C, Carducci P, Carreira PE, Castellví I, Del Galdo F, Distler JHW, Foeldvari I, Fraticelli P, George PM, Griffiths B, Guillén-Del-Castillo A, Hamid AM, Horváth R, Hughes M, Kreuter M, Moazedi-Fuerst F, Olas J, Paul S, Rotondo C, Rubio-Rivas M, Seferian A, Tomčík M, Uzunhan Y, Walker UA, Więsik-Szewczyk E, Distler O (2020) The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. The Lancet Rheumatology 2(2):e71–e83. https://doi.org/10.1016/S2665-9913(19)30144-4
doi: 10.1016/S2665-9913(19)30144-4
Volkmann ER, Chung A, Tashkin DP (2017) Managing systemic sclerosis-related interstitial lung disease in the modern treatment era. Journal of Scleroderma and Related Disorders 2(2):72–83. https://doi.org/10.5301/jsrd.5000237
doi: 10.5301/jsrd.5000237
Smith V, Scire CA, Talarico R, Airo P, Alexander T, Allanore Y, Bruni C, Codullo V, Dalm V, De Vries-Bouwstra J, Della Rossa A, Distler O, Galetti I, Launay D, Lepri G, Mathian A, Mouthon L, Ruaro B, Sulli A, Tincani A, Vandecasteele E, Vanhaecke A, Vanthuyne M, Van den Hoogen F, Van Vollenhoven R, Voskuyl AE, Zanatta E, Bombardieri S, Burmester G, Eurico FJ, Frank C, Hachulla E, Houssiau F, Mueller-Ladner U, Schneider M, van Laar JM, Vieira A, Cutolo M, Mosca M, Matucci-Cerinic M (2018) Systemic sclerosis: state of the art on clinical practice guidelines. RMD Open 4(Suppl 1):e000782. https://doi.org/10.1136/rmdopen-2018-000782
doi: 10.1136/rmdopen-2018-000782
pubmed: 30402270
pmcid: 6203100
Hartman TE, Swensen SJ, Hansell DM, Colby TV, Myers JL, Tazelaar HD, Nicholson AG, Wells AU, Ryu JH, Midthun DE, du Bois RM, Muller NL (2000) Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology 217(3):701–705. https://doi.org/10.1148/radiology.217.3.r00nv31701
doi: 10.1148/radiology.217.3.r00nv31701
pubmed: 11110931
Goldin JG, Lynch DA, Strollo DC, Suh RD, Schraufnagel DE, Clements PJ, Elashoff RM, Furst DE, Vasunilashorn S, MF MN-G, Brown MS, Roth MD, Tashkin DP, Scleroderma Lung Study Research G (2008) High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest 134(2):358–367. https://doi.org/10.1378/chest.07-2444
doi: 10.1378/chest.07-2444
pubmed: 18641099
Biederer J, Mirsadraee S, Beer M, Molinari F, Hintze C, Bauman G, Both M, Van Beek EJ, Wild J, Puderbach M (2012) MRI of the lung (3/3)-current applications and future perspectives. Insights Imaging 3(4):373–386. https://doi.org/10.1007/s13244-011-0142-z
doi: 10.1007/s13244-011-0142-z
pubmed: 22695943
pmcid: 3481076
Romei C, Turturici L, Tavanti L, Miedema J, Fiorini S, Marletta M, Wielopolski P, Tiddens H, Falaschi F, Ciet P (2018) The use of chest magnetic resonance imaging in interstitial lung disease: a systematic review. Eur Respir Rev 27(150). https://doi.org/10.1183/16000617.0062-2018
Lonzetti L, Zanon M, Pacini GS, Altmayer S, Martins de Oliveira D, Rubin AS, Gazzoni FF, Barros MC, Hochhegger B (2019) Magnetic resonance imaging of interstitial lung diseases: a state-of-the-art review. Respir Med 155:79–85. https://doi.org/10.1016/j.rmed.2019.07.006
doi: 10.1016/j.rmed.2019.07.006
pubmed: 31323528
Wild JM, Marshall H, Bock M, Schad LR, Jakob PM, Puderbach M, Molinari F, Van Beek EJ, Biederer J (2012) MRI of the lung (1/3): methods. Insights Imaging 3(4):345–353. https://doi.org/10.1007/s13244-012-0176-x
doi: 10.1007/s13244-012-0176-x
pubmed: 22695952
pmcid: 3481083
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Muller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 65(11):2737–2747. https://doi.org/10.1002/art.38098
doi: 10.1002/art.38098
pubmed: 24122180
pmcid: 3930146
Showalter K, Merkel PA, Khanna D, Gordon JK (2020) Assessment of skin disease in scleroderma: practices and opinions of investigators studying scleroderma. Journal of Scleroderma and Related Disorders 5(3):167–171. https://doi.org/10.1177/2397198320921044
doi: 10.1177/2397198320921044
Ruaro B, Nallino MG, Casabella A, Salton F, Confalonieri P, De Tanti A, Bruni C (2020) Monitoring the microcirculation in the diagnosis and follow-up of systemic sclerosis patients: focus on pulmonary and peripheral vascular manifestations. Microcirculation. doi: https://doi.org/10.1111/micc.12647
Suliman YA, Bruni C, Johnson SR, Praino E, Alemam M, Borazan N, Cometi L, Myers B, Khanna D, Allanore Y, Baron M, Krieg T, Herrick A, Afonso A, Distler O, Kafaja S, Denton CP, Matucci-Cerinic M, Furst DE (2017) Defining skin ulcers in systemic sclerosis: systematic literature review and proposed world Scleroderma Foundation (WSF) definition. Journal of Scleroderma and Related Disorders 2(2):115–120. https://doi.org/10.5301/jsrd.5000236
doi: 10.5301/jsrd.5000236
pubmed: 30569018
pmcid: 6296474
Barskova T, Gargani L, Guiducci S, Randone SB, Bruni C, Carnesecchi G, Conforti ML, Porta F, Pignone A, Caramella D, Picano E, Cerinic MM (2013) Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. Ann Rheum Dis 72(3):390–395. https://doi.org/10.1136/annrheumdis-2011-201072
doi: 10.1136/annrheumdis-2011-201072
pubmed: 22589373
Hoffmann-Vold AM, Allanore Y, Bendstrup E, Bruni C, Distler O, Maher TM, Wijsenbeek M, Kreuter M (2020) The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease. Respir Res 21(1):197. https://doi.org/10.1186/s12931-020-01459-0
doi: 10.1186/s12931-020-01459-0
pubmed: 32703199
pmcid: 7379834
Volpicelli G, Elbarbary M, Blaivas M, Lichtenstein DA, Mathis G, Kirkpatrick AW, Melniker L, Gargani L, Noble VE, Via G, Dean A, Tsung JW, Soldati G, Copetti R, Bouhemad B, Reissig A, Agricola E, Rouby JJ, Arbelot C, Liteplo A, Sargsyan A, Silva F, Hoppmann R, Breitkreutz R, Seibel A, Neri L, Storti E, Petrovic T, International Liaison Committee on Lung Ultrasound for International Consensus Conference on Lung U (2012) International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med 38(4):577–591. https://doi.org/10.1007/s00134-012-2513-4
doi: 10.1007/s00134-012-2513-4
pubmed: 22392031
Gargani L, Bruni C, Romei C, Frumento P, Moreo A, Agoston G, Guiducci S, Bellando-Randone S, Lepri G, Belloli L, Della Rossa A, Delle Sedie A, Stagnaro C, De Nes M, Salvadori S, Mosca M, Falaschi F, Epis O, Picano E, Matucci-Cerinic M (2020) Prognostic value of lung ultrasound B-lines in systemic sclerosis. Chest. https://doi.org/10.1016/j.chest.2020.03.075
Gargani L (2019) Ultrasound of the lungs: more than a room with a view. Heart Fail Clin 15(2):297–303. https://doi.org/10.1016/j.hfc.2018.12.010
doi: 10.1016/j.hfc.2018.12.010
pubmed: 30832819
Volkmann ER (2020) Natural history of systemic sclerosis–related interstitial lung disease: how to identify a progressive fibrosing phenotype. Journal of Scleroderma and Related Disorders 5(2_suppl):31–40. https://doi.org/10.1177/2397198319889549
doi: 10.1177/2397198319889549
pubmed: 33693056
Occhipinti M, Bruni C, Camiciottoli G, Bartolucci M, Bellando-Randone S, Bassetto A, Cuomo G, Giuggioli D, Ciardi G, Fabbrizzi A, Tomassetti S, Lavorini F, Pistolesi M, Colagrande S, Matucci-Cerinic M (2020) Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-217359
Picano E, Semelka R, Ravenel J, Matucci-Cerinic M (2014) Rheumatological diseases and cancer: the hidden variable of radiation exposure. Ann Rheum Dis 73(12):2065–2068. https://doi.org/10.1136/annrheumdis-2014-206585
doi: 10.1136/annrheumdis-2014-206585
pubmed: 25301819
Mirsadraee S, Tse M, Kershaw L, Semple S, Schembri N, Chin C, Murchison JT, Hirani N, van Beek EJ (2016) T1 characteristics of interstitial pulmonary fibrosis on 3T MRI-a predictor of early interstitial change?. Quant Imaging Med Surg 6 (1):42–49. doi: https://doi.org/10.3978/j.issn.2223-4292.2016.02.02
Pinal-Fernandez I, Pineda-Sanchez V, Pallisa-Nunez E, Simeon-Aznar CP, Selva-O'Callaghan A, Fonollosa-Pla V, Vilardell-Tarres M (2016) Fast 1.5 T chest MRI for the assessment of interstitial lung disease extent secondary to systemic sclerosis. Clin Rheumatol 35(9):2339–2345. https://doi.org/10.1007/s10067-016-3267-0
doi: 10.1007/s10067-016-3267-0
pubmed: 27107755
Ganesan KAD, Hackmann A, Laicher G, Chan P, Cutillo AG (1996) NMR relaxation and water self-diffusion mechanisms in lung. In: Cutillo AG e (ed) applications of magnetic resonance to the study of the lung. Futura, New York, pp 115–139
Stadler A, Jakob PM, Griswold M, Barth M, Bankier AA (2005) T1 mapping of the entire lung parenchyma: influence of the respiratory phase in healthy individuals. J Magn Reson Imaging 21(6):759–764. https://doi.org/10.1002/jmri.20319
doi: 10.1002/jmri.20319
pubmed: 15906333
Muller CS, Warszawiak D, Paiva EDS, Escuissato DL (2017) Pulmonary magnetic resonance imaging is similar to chest tomography in detecting inflammation in patients with systemic sclerosis. Rev Bras Reumatol Engl Ed 57(5):419–424. https://doi.org/10.1016/j.rbre.2017.02.001
doi: 10.1016/j.rbre.2017.02.001
pubmed: 29037314
Ohno Y, Nishio M, Koyama H, Takenaka D, Takahashi M, Yoshikawa T, Matsumoto S, Obara M, van Cauteren M, Sugimura K (2013) Pulmonary MR imaging with ultra-short TEs: utility for disease severity assessment of connective tissue disease patients. Eur J Radiol 82(8):1359–1365. https://doi.org/10.1016/j.ejrad.2013.02.031
doi: 10.1016/j.ejrad.2013.02.031
pubmed: 23523024
Roofeh D, Distler O, Allanore Y, Denton CP, Khanna D (2020) Treatment of systemic sclerosis–associated interstitial lung disease: lessons from clinical trials. Journal of Scleroderma and Related Disorders 5(2_suppl):61–71. https://doi.org/10.1177/2397198320903208
doi: 10.1177/2397198320903208
Lepri G, Hughes M, Bruni C, Cerinic MM, Randone SB (2020) Recent advances steer the future of systemic sclerosis toward precision medicine. Clin Rheumatol 39(1):1–4. https://doi.org/10.1007/s10067-019-04834-5
doi: 10.1007/s10067-019-04834-5
pubmed: 31760537
Picano E, Matucci-Cerinic M (2011) Unnecessary radiation exposure from medical imaging in the rheumatology patient. Rheumatology (Oxford) 50(9):1537–1539. https://doi.org/10.1093/rheumatology/keq412
doi: 10.1093/rheumatology/keq412